What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Diabetes mellitus
- Endocrinology
Eleuterio Ferrannini mainly investigates Internal medicine, Endocrinology, Insulin, Diabetes mellitus and Insulin resistance.
His research in Internal medicine tackles topics such as Type 2 diabetes which are related to areas like Metformin and Surgery.
His work in Endocrinology addresses issues such as Splanchnic, which are connected to fields such as Peripheral.
His work focuses on many connections between Insulin and other disciplines, such as Fatty acid, that overlap with his field of interest in Gluconeogenesis, Heparin, Peptide hormone, Lipolysis and Randle cycle.
His Type 2 Diabetes Mellitus and Postprandial study, which is part of a larger body of work in Diabetes mellitus, is frequently linked to Lipid oxidation and Context, bridging the gap between disciplines.
His work carried out in the field of Insulin resistance brings together such families of science as Glycogen synthase, Metabolic syndrome and Beta cell.
His most cited work include:
- Insulin Resistance: A Multifaceted Syndrome Responsible for NIDDM, Obesity, Hypertension, Dyslipidemia, and Atherosclerotic Cardiovascular Disease (3945 citations)
- Insulin resistance in essential hypertension (2146 citations)
- Pathogenesis of NIDDM: A balanced overview (1882 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Internal medicine, Endocrinology, Insulin, Insulin resistance and Diabetes mellitus.
His research integrates issues of Type 2 diabetes and Cardiology in his study of Internal medicine.
His study in Glucose uptake, Hyperinsulinemia, Glucose tolerance test, Basal and Pancreatic hormone are all subfields of Endocrinology.
His Insulin study integrates concerns from other disciplines, such as Hormone and Blood pressure.
His Insulin resistance research is multidisciplinary, relying on both Body mass index and Metabolic syndrome.
A large part of his Diabetes mellitus studies is devoted to Type 2 Diabetes Mellitus.
He most often published in these fields:
- Internal medicine (93.09%)
- Endocrinology (77.13%)
- Insulin (46.28%)
What were the highlights of his more recent work (between 2006-2020)?
- Internal medicine (93.09%)
- Endocrinology (77.13%)
- Type 2 diabetes (16.22%)
In recent papers he was focusing on the following fields of study:
Eleuterio Ferrannini focuses on Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Insulin resistance.
His Internal medicine study incorporates themes from Gastroenterology and Cardiology.
Insulin, Glucose tolerance test, Type 2 Diabetes Mellitus, Adipose tissue and Body mass index are the core of his Endocrinology study.
The study incorporates disciplines such as Glucagon-like peptide-1 and Carbohydrate metabolism in addition to Insulin.
His study in Type 2 diabetes is interdisciplinary in nature, drawing from both Surgery, Bioinformatics, Pancreatic hormone, Endothelial dysfunction and Endothelium.
His study in the fields of American diabetes association, Dyslipidemia and Type 1 diabetes under the domain of Diabetes mellitus overlaps with other disciplines such as Position statement and Patient centered.
Between 2006 and 2020, his most popular works were:
- Management of hyperglycemia in type 2 diabetes: a patient-centered approach. Position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD). Diabetes Care 2012;35:1364–1379 (810 citations)
- Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. (615 citations)
- SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects (277 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Diabetes mellitus
- Endocrinology
Internal medicine, Endocrinology, Type 2 diabetes, Diabetes mellitus and Insulin resistance are his primary areas of study.
His study brings together the fields of Gastroenterology and Internal medicine.
His Type 2 diabetes study deals with Adipose tissue intersecting with Adiponectin receptor 1, Adiponectin receptor 2, Hyperinsulinemia, Dyslipidemia and Thyroid hormone receptor.
His Diabetes mellitus research is multidisciplinary, incorporating elements of Glucagon and Disease.
His study in Insulin resistance is interdisciplinary in nature, drawing from both Adipocyte, Zinc Transporter 8 and Polymorphism.
The study incorporates disciplines such as Glucagon-like peptide-1 and Nitric oxide synthase in addition to Insulin.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
